American Psychosocial Oncology Society Issues Call for 2015 Award Nominations
The American Pyschosocial Oncology Society (APOS) announced today that it is accepting nominations for its 2015 awards. The deadline for submitting nominations is December 31, 2014. These awards will be presented at the World Congress of Psycho-Oncology, to be held July 30 to August 1, 2015. For detailed information on the awards, including eligibility criteria and past recipients, and to download a nomination form, visit www.apos-society.org/about/awards/awards_info.aspx.
APOS is accepting nominations for the following awards:
- Holland Distinguished Leadership Award honors a psychosocial oncology community member who has made an outstanding contribution to the field in practice, education, research and leadership
- Distinguished Public Service Award is presented to a psychosocial oncology community leader in recognition of outstanding contributions to the field of psychosocial oncology at the national level
- Outstanding Clinical Care Award is presented to a clinician in recognition of outstanding clinical contributions to the field of psychosocial oncology (nominees must be licensed and actively practicing in the field of psychosocial oncology for a minimum of 5 years)
- Outstanding Education and Training Award is presented to a leader who has enhanced the field of psychosocial oncology through the education and training of new investigators and clinicians
- New Investigator Award is presented to an APOS member for his or her research contributions (nominees must be APOS members within 5 years of completing their highest level of training—eg, graduate training, medical or postdoctoral fellowship, or equivalent specialist training)
The deadline to submit award nominations is December 31, 2014. Please contact APOS Headquarters with any questions about the awards or the nomination process by e-mail at info@apos-society.org or by telephone at 1-434-293-5350.
The content in this post has not been reviewed by the American Society of Clinical Oncology, Inc. (ASCO®) and does not necessarily reflect the ideas and opinions of ASCO®.
